High affinity antagonists of the vanilloid receptor

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• The vanilloid receptor 1 (VR1) is a key sensory transducer for capsaicin, heat, and protons.
• VR1 antagonists are of significant therapeutic interest for pain and inflammation management.
• Existing antagonists like capsazepine have limitations in potency and selectivity.

Purpose of the Study:

• To characterize two novel VR1 antagonists, KJM429 and JYL1421.
• To compare their potency and mechanism of action against capsazepine.
• To investigate their differential effects on VR1 activation by various stimuli.

Main Methods:

• Characterization of KJM429 and JYL1421 in rat VR1 (rVR1) expressed in Chinese hamster ovary (CHO) cells.
• Assays included [(3)H]resiniferatoxin binding and capsaicin-induced calcium uptake.
• Evaluation of responses to heat, pH, and ATP in CHO cells and cultured dorsal root ganglion neurons.

Main Results:

• JYL1421 demonstrated significantly higher potency than capsazepine in inhibiting RTX binding and antagonizing capsaicin-induced calcium uptake.
• Both compounds acted as competitive antagonists for capsaicin and RTX.
• JYL1421 antagonized heat and pH (6.0, 5.5) responses, while KJM429 showed differential effects, acting as an agonist at lower pH (<5.5).
• Antagonism was confirmed in dorsal root ganglion neurons, with minimal effect on ATP-induced responses in VR1-negative cells.

Conclusions:

• JYL1421 is a potent, competitive antagonist of rat VR1, effectively blocking responses to capsaicin, heat, and protons.
• KJM429 exhibits distinct pharmacological properties, including agonist activity at low pH.
• These novel antagonists offer improved potency and potentially differential selectivity for VR1-mediated signaling pathways.